SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-387367
Filing Date
2012-09-11
Accepted
2012-09-11 08:26:00
Documents
4
Period of Report
2012-09-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d409650d8k.htm 8-K 15948
2 PRESS RELEASE d409650dex991.htm EX-99.1 13646
3 GRAPHIC g409650g17w38.jpg GRAPHIC 5809
4 GRAPHIC g409650g53b89.jpg GRAPHIC 5683
  Complete submission text file 0001193125-12-387367.txt   46975
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 121084452
SIC: 2834 Pharmaceutical Preparations